Opioid Liability Claims: Coverage and Litigation Considerations for Manufacturers, Distributors, Third-Party Payors
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will explore insurance coverage issues related to the expanding breadth of opioid liability claims. Our panel will discuss coverage considerations, the increasing reach of these claims for those involved in the manufacture, distribution, prescription or payment for opioids, and the developing body of related case law.
- Opioid liability claims
- Coverage issues
- Policy types
- Practical steps
The panel will review these and other critical issues:
- How should insurers and policyholders address explicit cooperation obligations in the claims process?
- What impact will opioid-related claims have on policy terms for policyholders moving forward?
Anna P. Engh
Covington & Burling
Ms. Engh has a wide range of experience in the insurance coverage area. She has handled coverage litigation and... | Read More
Ms. Engh has a wide range of experience in the insurance coverage area. She has handled coverage litigation and negotiated insurance recoveries on behalf of corporate policyholders for a variety of claims, including asbestos, lead, and other mass tort claims; environmental liabilities; first party property damage; directors and officers and errors and omissions claims; and political risks.Close
Adam H. Fleischer
As Chair of the nation’s first Opioid Coverage Task Force, Mr. Fleischer is actively engaged in the insurance... | Read More
As Chair of the nation’s first Opioid Coverage Task Force, Mr. Fleischer is actively engaged in the insurance aspects of suits across the country against manufacturers and distributors of opioids, as well as serving as a frequent author and lecturer on this cutting-edge topic. He has a national reputation for innovative advocacy in complex insurance and reinsurance coverage issues with respect to the pre-litigation, litigation and appellate stages. Mr. Fleischer has represented his insurance and reinsurance clients in analyzing and evaluating many complex high profile cases.Close